期刊文献+

肺结核合并糖尿病患者治疗的临床隐患及对策

Clinical Hidden Dangers and Countermeasures of Pulmonary Tuberculosis Complicated with Diabetes Mellitus
在线阅读 下载PDF
导出
摘要 目的分析肺结核合并糖尿病患者接受治疗的临床隐患及对策。方法选择我院肺结核合并糖尿病患者60例为本次实验的调查研究对象,对60例肺结核合并糖尿病患者的抗结核药物不良反应、糖尿病并发症的发生率等进行分析,另选取60例非糖尿病肺结核患者为对照组,分析肺结核合并糖尿病患者和非糖尿病肺结核患者的临床隐患、对策。结果血糖水平控制良好者肺结核治疗有效率高于血糖水平控制一般、较差患者(P<0.05);肺结核合并糖尿病患者不良反应率高于非糖尿病肺结核患者(P<0.05)。结论肺结核合并糖尿病患者对结核药物出现发热、中枢神经系统、关节肿痛、胃肠道反应、肝功能损伤等不良反应发生率会高于非糖尿病肺结核患者,血糖控制水平与结核治愈率具有较大关系,提高治疗依从性,在治疗过程中出现药物不良反应时,给予记录分析,调整药物,积极控制血糖水平等,可提高临床治愈率、生活质量。 Objective To analyze the clinical hidden dangers and countermeasures of pulmonary tuberculosis complicated with diabetes.Methods Sixty cases of pulmonary tuberculosis complicated with diabetes mellitus in our hospital were selected as the research objects of this experiment.The adverse drug reactions of anti tuberculosis drugs and the incidence of diabetic complications in 60 cases of pulmonary tuberculosis complicated with diabetes were analyzed.Another 60 cases of non-diabetic pulmonary tuberculosis patients were selected as the control group.Analyze the clinical hidden dangers and countermeasures of pulmonary tuberculosis patients with diabetes mellitus and non-diabetic pulmonary tuberculosis.Results The effective rate of pulmonary tuberculosis patients with good blood glucose level control was higher than that of patients with general and poor blood glucose control(P<0.05).The adverse reaction rate of pulmonary tuberculosis patients with diabetes mellitus was higher than that of non-diabetic pulmonary tuberculosis patients(P<0.05).Conclusion The incidence of fever,central nervous system,joint swelling and pain,gastrointestinal reaction,liver function injury and other adverse reactions in patients with pulmonary tuberculosis and diabetes mellitus will be higher than those in patients with non-diabetic pulmonary tuberculosis.The level of blood glucose control has a great relationship with the cure rate of tuberculosis,so as to improve the treatment compliance.In the course of treatment,adverse drug reactions should be recorded and analyzed,drugs should be adjusted,and blood glucose level should be actively controlled,which can improve the clinical cure rate and quality of life.
作者 娜迪热·阿不都萨拉木 木巴热克·艾买提 张光辉 Nadire·Abudusalamu;Mubareke·Aimaiti;ZHANG Guang-hui(The Sixth People's Hospital of Xinjiang Uygur Autonomous Region,Urumqi,Xinjiang 830001)
出处 《智慧健康》 2020年第34期193-194,共2页 Smart Healthcare
关键词 肺结核 胃肠道反应 血糖 症状 Pulmonary tuberculosis Gastrointestinal reaction Blood glucose Symptoms
  • 相关文献

二级参考文献55

  • 1Yang WY, Lu JM, Weng JP, et al. Prevalence of diabetes among men and women in China[ J ]. N Engl J Med ,2010,362 ( 12 ) : 1090-1101.
  • 2American Diabets Association. Standards of medical care in diabetes- 2010 [ J ]. Diabetes Care,2010,33 ( S1 ) : S1-S61.
  • 3The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and pro- gression of long-term complications in insulin-dependent diabetes mellitus[ J]. N Engl J Med,1993,329(14) :977-986.
  • 4UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glu- cose control with sulphonylureas or insulin compared with convention- al treatment and risk of complications in patients with type 2 diabetes ( UKPDS 33) [ J]. Lancet,1998,352(9131 ) :837-853.
  • 5The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes [ J ]. N Engl J Med, 2008,358 ( 19 ) : 1991-2002.
  • 6Roberts WL, Safar-Pour S, Barun K, et al. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods [J]. Clin Chem, 2005,51 (4) :776-778.
  • 7Abadie JM, Koeleh AA. Performance of the Roche second genera- tion hemoglobin A1 c immunoassay in the presence of Hb-S and Hb- C traits[J]. Ann Clin Lab Sci,2008,38( 1 ) :31-36.
  • 8Peterson C M, Jovanovic L, Raskin P,et al. A comparative evaluation of glycosylated haemoglobin assays: feasibility of references and standards [ J ]. Diabetologia, 1984, 26 ( 3 ) :214-217.
  • 9IFCC. Approved IFCC reference method for the measurement of HbAlc in human blood[ J]. Clin Chem Lab Med,2002,40( 1 ) :78- 89.
  • 10Iguchi K, Nakanishi T, Miyazaki A, et al. Development of an iso- tope dilution mass spectrometry assay for HbA1 c based on enzyme- cleaved peptide analysis [ J ]. J Chromatogr B Analyt Technol Bi- omed Life Sci,2004,806( 1 ) :25-31.

共引文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部